B2M and Parkinson disease: Of interest, high CSF levels of β2m were detected in neurodegenerative conditions, such as Alzheimer's disease (AD) and Parkinson's disease (PD) (56–59), which are caused by protein misfolding and abnormal aggregation (60), but the potential pathogenetic significance of this finding is still unclear.